Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyWarburg effect and translocation-induced genomic instability: two yeast models for cancer cellsZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65Applications of metabolomics in cancer researchMammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthNo evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesisStable isotope-resolved metabolomics and applications for drug developmentMitochondria in Cancer Energy Metabolism: Culprits or Bystanders?The sweet trap in tumors: aerobic glycolysis and potential targets for therapyEnergy metabolism in neurodevelopment and medulloblastomaInterplay Between Metabolism and Oncogenic Process: Role of microRNAsTargeting amino acid metabolism in cancer growth and anti-tumor immune response6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signallingPyruvate kinase: Function, regulation and role in cancerAutophagy in stem cells.Application of metabolomics in drug resistant breast cancer researchBioinformatics and systems biologyPyruvate kinase M2 at a glancePyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesisSerine is a natural ligand and allosteric activator of pyruvate kinase M2Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformationHeterogeneity of glycolysis in cancers and therapeutic opportunities.ROS homeostasis and metabolism: a critical liaison for cancer therapyInfection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infectionMitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availabilityIdentification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancerBioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancerMetabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophyVariations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent StatesAssessment of FBA Based Gene Essentiality Analysis in Cancer with a Fast Context-Specific Network Reconstruction MethodThe space of enzyme regulation in HeLa cells can be inferred from its intracellular metabolomeMetabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancerMetabolic reprogramming: a cancer hallmark even warburg did not anticipateProteomic screening method for phosphopeptide motif binding proteins using peptide libraries.A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death.Role of Increased n-acetylaspartate Levels in Cancer.Integrating gene and protein expression data with genome-scale metabolic networks to infer functional pathwaysAnalysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized SuccinateStress-induced cleavage of Myc promotes cancer cell survival
P2860
Q21129303-4F9B7264-B767-4ABA-B4C8-0542FB7C0A77Q21129304-378453AA-9180-4ECE-8420-5E44CDABE80DQ24315863-C40DDB8D-18AF-42F4-81D9-559B284AC22EQ24600728-D847A08E-5008-4979-9D07-1BCACFC29512Q24603549-5C3A9E26-EB5C-47FB-BEEF-B338EC95E8A2Q24617359-9958E36E-FAFA-4942-8EE1-7AEAB7FE825CQ24629149-11D459C0-9DB8-4B09-AC6B-B51E0F2498B1Q26766062-DD5CE803-84F8-479D-B2F0-E7F21539F07BQ26766079-078BAE78-70C6-48FD-A44E-690619B708E1Q26770345-42609D3E-CA30-4AE5-BA6C-C8A144998601Q26770381-D2131460-BDA7-4088-9616-2D167E277997Q26775425-FCA37D5F-8E24-4C55-B8BA-89E33D230047Q26781896-942E96C3-30EA-468B-BA7C-CB69CF2B4D05Q26798084-97DE1DD8-7216-432A-8875-C4DA530A2818Q26823995-55AADBDB-A77F-4CBF-A712-6B69E619D6D7Q26866291-09ED2E81-5B93-4AB9-A6C7-00832483FDD9Q27005417-99D39F9D-7BA6-467B-A8FF-F93FB1462AE1Q27005722-93463816-6D77-474B-B00A-95A99434042AQ27671695-926D0991-E735-4FA6-84BD-49003CF08473Q27674495-03205DAF-A72F-4D36-B17B-D07889447487Q27678039-5D3CEAE2-DAFC-4F99-95E4-35668BBC7475Q27693375-0400300A-0CC6-4064-A7E7-295A775AA1C8Q28080316-DFDD0575-7A9D-439F-AA61-8CC7230EADB2Q28083186-56B643F8-293E-4892-ACB6-E0E31F4703A2Q28242891-B98E79E0-C719-42D5-9648-0A4CA8F2DFBAQ28478197-905EFF61-6346-429D-9D30-1B90173457B7Q28486165-ADFBAD02-1E04-41D4-9443-4B8B3C54F03FQ28546070-DC36637F-BAF9-43A1-B67E-CEB2C46BA310Q28550951-EAA224E5-6C05-4EBD-8CEE-E77975E2D0EEQ28551811-1FA316BF-11BB-4925-835F-3D7742A5E47BQ28597558-5DE356F0-449F-4CA1-A44C-D6CB05BDFBABQ28609305-02EE5225-2448-4E0F-B1F2-2FC696C5850EQ29617612-E3486AF7-F1AD-497C-B4C7-20F367CCEC1CQ30010270-4C9244AF-FB37-418B-A51B-D2952A9AC500Q30423585-A2912A66-3125-44D7-955B-9E65A6736D74Q30488862-1D870B34-F666-44F0-A021-D8E6DCE88F86Q30710200-A1BB99AA-0D18-4D85-95E6-7D11BE81364BQ30928926-754119E9-B003-4912-8B6C-56904084940EQ31122753-7078ECCD-7A03-4C12-B359-B5D22C1C586BQ33588071-BC9F3355-28E3-4B7D-B315-4CB3CDCAA2BF
P2860
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@ast
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@en
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@nl
type
label
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@ast
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@en
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@nl
prefLabel
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@ast
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@en
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
@en
P2093
Daniel Amador-Noguez
Gerhard Wagner
Greg J Heffron
Hadar Sharfi
John M Asara
Joshua D Rabinowitz
Kenneth D Swanson
Matthew G Vander Heiden
P2860
P304
P356
10.1126/SCIENCE.1188015
P407
P577
2010-09-01T00:00:00Z